Literature DB >> 1491667

Tetanus surveillance--United States, 1989-1990.

R Prevots, R W Sutter, P M Strebel, S L Cochi, S Hadler.   

Abstract

During the period 1989-1990, 117 cases of tetanus were reported from 34 states, for an average annual incidence of 0.02/100,000 population. Fifty-eight percent of patients were > or = 60 years of age, while seven (6%) were < 20 years of age, including one case of neonatal tetanus. Among adults, the risk of tetanus in those > 80 years of age was more than 10 times the risk in persons ages 20-29 years. The case-fatality rate increased with age, from 17% in persons 40-49 years of age to 50% in those > or = 80 years of age. Only 11% of patients reported having received a primary series of tetanus toxoid before disease onset, while 31% lacked a history of tetanus vaccination. Tetanus occurred following an acute injury in 78% of patients. Of patients who sought medical care, only 58% received tetanus toxoid as part of wound prophylaxis. Tetanus remains a severe disease that primarily affects unvaccinated or inadequately vaccinated older adults. Increased efforts are needed to reduce the risk of tetanus among the elderly. Health-care providers should take every opportunity to review the vaccination status of their patients and provide tetanus vaccine when indicated.

Entities:  

Mesh:

Year:  1992        PMID: 1491667

Source DB:  PubMed          Journal:  MMWR CDC Surveill Summ


  5 in total

1.  Tetanus in an immunised patient.

Authors:  Z Shimoni; A Dobrousin; J Cohen; S Pitlik
Journal:  BMJ       Date:  1999-10-16

2.  Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of age.

Authors:  Vincent Gajdos; Benoit Soubeyrand; Emmanuel Vidor; Patrick Richard; Julie Boyer; Christine Sadorge; Anne Fiquet
Journal:  Hum Vaccin       Date:  2011-05-01

3.  Evaluation and validation of a monoclonal immunofluorescent reagent for direct detection of Bordetella pertussis.

Authors:  P McNicol; S M Giercke; M Gray; D Martin; B Brodeur; M S Peppler; T Williams; G Hammond
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

Review 4.  Immunodeficiency of aging.

Authors:  E A Burns; J S Goodwin
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 4.271

5.  Clinician awareness of tetanus-diphtheria vaccination in trauma patients: a questionnaire study.

Authors:  Young-Hoon Yoon; Sung-Woo Moon; Sung-Hyuk Choi; Young-Duck Cho; Jung-Youn Kim; Young Ho Kwak
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-05-15       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.